About Prescribe
Prescribe is a company based in Malappuram (India) founded in 2019 by Amit Kumar Verma, Nived Narayanan, and Sreeshyam C A. It operates as a B2B. Prescribe has raised $260.94 thousand across 2 funding rounds from investors including Angel List, Wellfound and First Cheque. Prescribe operates in a competitive market with competitors including Wheel, SnapMD, mediQ, Signo Motus and HealtheMed, among others.
- Headquarter Malappuram, India
- Founders Amit Kumar Verma, Nived Narayanan, Sreeshyam C A
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Wellnexus Technologies Private Limited
- Date of Incorporation 21 Nov, 2019
- Jurisdiction Malappuram, Kerala, India
-
Annual Revenue
$17.53 K (USD)145.56as on Mar 31, 2022
-
Net Profit
-$8.81 K (USD)92.03as on Mar 31, 2022
-
EBITDA
-$7.95 K (USD)92.73as on Mar 31, 2022
-
Total Equity Funding
$260.94 K (USD)
in 2 rounds
-
Latest Funding Round
$125 K (USD), Seed
Mar 23, 2021
-
Investors
Angel List
& 11 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Prescribe
Unlock access to complete
Unlock access to complete
Funding Insights of Prescribe
Prescribe has successfully raised a total of $260.94K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $125 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Prescribe
Prescribe has secured backing from 12 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Angel List, Wellfound and First Cheque.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked | |
|
Investments are made in early-stage companies by Titan Capital.
|
Locked | Locked | Locked | |
|
Early-stage investment and support services for startups in technology and e-commerce sectors.
|
Locked | Locked | Locked |
Investor details for Prescribe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prescribe
Investment portfolio details for Prescribe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prescribe
Detailed financials for Prescribe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prescribe Comparisons
Peer comparison for Prescribe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prescribe
Prescribe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wheel, SnapMD, mediQ, Signo Motus and HealtheMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Virtual care platform is provided for healthcare companies.
|
|
| Locked | Locked | Locked |
Cloud-based telemedicine platform for provider consultations is provided.
|
|
| Locked | Locked | Locked |
Virtual healthcare services are delivered via a mobile application.
|
|
| Locked | Locked | Locked |
Robotics and software solutions are provided for hospitals and doctors.
|
|
| Locked | Locked | Locked |
Provider of integrated digital system solution services
|
|
| Locked | Locked | Locked |
Real-time video communications solutions are offered for health enterprises.
|
Detailed competitors of Prescribe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prescribe
Complete news archive for Prescribe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prescribe
Prescribe was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Prescribe is headquartered in Malappuram, India. It is registered at Malappuram, Kerala, India.
Prescribe is a funded company, having raised a total of $260.94K across 2 funding rounds to date.
Annual revenue of Prescribe is $17.53K as on Mar 31, 2022.
Prescribe, backed by 260940.0 from Y Combinator, Rohit Kumar Bansal, Titan Capital, Mudit Vijayvergiya, Nipun Goyal, Pawan Gupta, Kunal Bahl, Wellfound, First Cheque, Angel List, AngelList, Rohit Bansal, focuses on providing healthcare solutions, providing digital health services, health management platforms, and ai solutions. Functions as an AI-based platform for health management, supporting doctors and patients with advanced tools. Driving innovation, growth, and excellence in its industry sectors.
Prescribe has 12 investors. Key investors include Angel List, Wellfound, First Cheque, Y Combinator, and Rohit Kumar Bansal.
The valuation of Prescribe is $897.94K as of Sep 2020.